Note: Ingredients listed on restricted chemical lists
EC/CAS
74-31-7
Name of the chemical
N,N'-Diphenyl-p-phenylenediamine
Concentration
(%
General Information
Revision date
2009-03-16
Product name
N,N"-Diphenyl-1,4-phenylenediamine
Product Synonyms
4-Phenylaminodiphenylamine
Chemical name
N,N"-Diphenyl-1,4-phenylenediamine
CAS No.
74-31-7
supplier name
TCI America
Emergency telephone
(800) 424-9300, (703) 527-3887
Icons in SDS
Company Information
company name
TCI America
Section 2
SECTION 2: Hazards identification
Potential Acute Health Effects
Irritating to eyes and skin on contact. Inhalation causes irritation of the lungs and respiratory system. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering. Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Potential chronic health
CARCINOGENIC EFFECTS : Not available. MUTAGENIC EFFECTS : Not available.
Teratogenic Effects
Tumorigenic Effects Mouse TDLo (subcutaneous) 1000 mg/kg Toxic Effects: Tumorigenic - Equivocal tumorigenic agent by RTECS criteria. Lung, Thorax, or Respiration - Tumors. Blood - Tumors. DEVELOPMENTAL TOXICITY: Reproductive Effects: Rat TDLo (oral) 2500 mg/kg, female 1-22 days of pregnancy. Toxic Effects: Effects on Fertility - Post-implantation mortality. Rat TDLo (oral) 450 mg.kg, female 14 days prior to mating and 1-22 days of pregnancy. Toxic Effects: Maternal Effects - Parturition. Effects on Newborn - Stillbirth. Mouse TDLo (oral) 4176 mg/kg, female 6-14 days of pregnancy. Toxic Effects: Effects on Embryo or Fetus - Extra embryonic structures. Repeated or prolonged exposure to this compound is not known to aggravate existing medical conditions. Section IV.
